Zoom In on Kid Vaccines: Four Free Public Chats Coming
Published Date: 12/16/2025
Notice
Summary
The Advisory Commission on Childhood Vaccines (ACCV) will hold four public virtual meetings in late 2025 to discuss vaccine injury compensation and related updates. These meetings affect families, healthcare providers, and anyone interested in vaccine safety and support programs. While no decisions will be made, the sessions offer a chance to stay informed about important vaccine policies and programs, with registration required to join online.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Four public virtual ACCV sessions
The Advisory Commission on Childhood Vaccines (ACCV) will hold four public virtual meetings on December 29, 2025 at 11:30 a.m., 12:00 p.m., 12:30 p.m., and 1:00 p.m. Eastern Time. The meetings will discuss vaccine injury compensation and related updates and are open to families, healthcare providers, and anyone interested in vaccine safety.
Registration required to join online
Meetings will be held as Microsoft Teams webinars and require registration on the ACCV website. All registrants must provide their name, affiliation, and email address and will receive Microsoft Teams access information by email.
How to submit public comments
Members of the public may submit written statements in advance and may request to give oral comments; written statements should be sent to Pita Gomez at least 5 business days before the meeting date(s). Oral comments will be taken in the order requested and may be time-limited.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16871, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Maternity and Obstetrics Management Strategies Program Data Collection, OMB No. 0915-0394-Revision
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-16396, National Newborn Screening Stakeholder Workgroup
HRSA provides funding to support a national center for newborn screening systems known as the National Center for Newborn Screening Systems Excellence (NBS Excel). In fiscal year 2026, supplemental funding is being provided to NBS Excel to establish a national newborn screening stakeholder workgroup. This workgroup will be a pathway for conditions to be considered and recommended for inclusion in the Recommended Uniform Screening Panel (RUSP) and to discuss national- level issues related to newborn screening. Membership will include representatives from a wide range of newborn screening experts and stakeholders. The award recipient will convene the workgroup and develop findings, reports, and recommendations for HRSA's review and consideration. HRSA will then make recommendations to the Secretary of Health and Human Services, who has final decision-making authority on updates to the RUSP.
2026-16227, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Transforming Pediatrics for Early Childhood Program Performance Measures
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-16054, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-15596, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; National Health Service Corps Scholar/Students to Service Travel Worksheet, OMB No. 0906-0087-Revision
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-15633, Notice Regarding 340B Rebate Model Pilot Program
The U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program (340B Program), is issuing this Notice to announce the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Consistent with HRSA's longstanding statutory authority, rebates will be used instead of upfront discounts. HRSA issued a Request for Information (RFI) \1\ to gather input from interested parties regarding the potential use of rebates to effectuate the ceiling price under the 340B Program, including the standards and procedures that should govern the approval of manufacturer rebate plans and the impacts on all stakeholders. After carefully considering all comments from interested parties and different policy alternatives, HRSA is announcing this Pilot, which will implement a rebate approach for a limited set of drugs, and which builds on established and successful rebate programs. ---------------------------------------------------------------------------
Previous / Next Documents
Previous: 2025-22981, Proposed Collection; Comment Request
The Marine Corps Marathon wants your thoughts! They’re asking runners and fans to help by filling out a quick survey about their race experience and its impact. You’ve got until February 17, 2026, to share your feedback, which helps improve future marathons without costing you a dime or much time.
Next: 2025-22983, Office of the Director, National Institutes of Health; Notice of Meeting
The Office of AIDS Research Advisory Council is holding a virtual meeting on January 29, 2026, to share updates on HIV research plans and priorities. Anyone interested can watch online, join in, or send comments ahead of time. This meeting helps guide important decisions about HIV research funding and focus, affecting scientists, healthcare workers, and the public.